Tower Research Capital LLC (TRC) - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 44 filers reported holding MIRAGEN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,000
-95.5%
2,365
-77.9%
0.00%
-100.0%
Q2 2019$22,000
+29.4%
10,682
+77.6%
0.00%0.0%
Q1 2019$17,000
+13.3%
6,016
+22.7%
0.00%0.0%
Q4 2018$15,000
-55.9%
4,905
-20.6%
0.00%
-50.0%
Q3 2018$34,000
+78.9%
6,178
+105.2%
0.00%
+100.0%
Q2 2018$19,000
-78.7%
3,010
-76.2%
0.00%
-87.5%
Q1 2018$89,000
+535.7%
12,672
+725.0%
0.01%
+700.0%
Q3 2017$14,0001,5360.00%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 30,497$502,0000.04%
DRIEHAUS CAPITAL MANAGEMENT LLC 33,333$548,0000.01%
View complete list of MIRAGEN THERAPEUTICS INC shareholders